The efficacy and safety of Zuranolone for treatment of depression: A systematic review and meta-analysis.

Psychopharmacology (Berl) · 2024 · PMC11199213 · PMID 38802705

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

2023a ) reported improvement in HAMD-17 scores and insomnia symptom score showed nominally significant differences in the zuranolone 20 mg groups when compared with the placebo group at Day 15.

also in 7,732 other papers

did not reach statistical significanceno p-value reported

While the 30-mg dose showed a nominally higher TEAE risk than the 20-mg dose, this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.